<DOC>
	<DOCNO>NCT02138890</DOCNO>
	<brief_summary>This double-blind , multicenter , randomize , control trial ( RCT ) evaluate efficacy single dose Autologous Protein Solution ( APS ) patient osteoarthritis ( OA ) knee fail least 1 conservative osteoarthritis ( OA ) therapy ( e.g . physiotherapy , simple analgesic , intra-articular injection ) .</brief_summary>
	<brief_title>APSS-33-00 : A Multicenter , Pilot Study Autologous Protein Solution ( APS ) Knee Osteoarthritis ( OA )</brief_title>
	<detailed_description>A double-blind , multicenter , randomize , control trial ( RCT ) evaluate efficacy single dose Autologous Protein Solution ( APS ) patient Osteoarthritis ( OA ) knee fail least 1 conservative OA therapy ( e.g . physiotherapy , simple analgesic , intra-articular injection ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Male female ≥40 year ≤75 year . Willingness ability comply study procedure visit schedule ability follow verbal write instruction . Diagnosis knee osteoarthritis ( OA ) Grade 2 3 accord KellgrenLawrence scale Body mass index ( BMI ) ≤ 40 . Failed least 1 conservative OA therapy Signed independent ethic committee ( IEC ) approve informed consent form ( ICF ) . Intraarticular Hyaluronic ( HA ) injection within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Autologous Protein Solution</keyword>
	<keyword>APS</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Intra Articular Injection</keyword>
</DOC>